South Carolina sues drug manufacturer over opioid crisis

August 15, 2017 by Meg Kinnard
South Carolina Attorney General Alan Wilson, left, stands next to Rep. Eric Bedingfield, whose son died last year of a drug overdose, on Tuesday, Aug. 15, 2017, at his offices in Columbia, S.C. Wilson on Tuesday announced the state had sued Purdue Pharma, accusing the maker of OxyContin and other opioid drugs of violating South Carolina's Unfair Trade Practices Act. (AP Photo/Meg Kinnard)

South Carolina has become the latest state to accuse a drug manufacturer of exacerbating its opioid drug crisis by using deceptive marketing, with the state's top prosecutor suing the maker of OxyContin.

Attorney General Alan Wilson on Tuesday announced the state had sued Purdue Pharma, accusing the maker of OxyContin and other opioid drugs of violating South Carolina's Unfair Trade Practices Act.

"While we vigorously deny the allegations, we share South Carolina officials' concerns about the opioid crisis and we are committed to working collaboratively to find solutions," Purdue Pharma responded in a statement.

The suit, filed in Richland County, accuses Purdue of failing to comply with a 2007 agreement it signed with South Carolina and dozens of other states over allegations of its promotion of OxyContin. Purdue admitted no fault in that case, which accused the company of encouraging doctors to prescribe OxyContin for unapproved uses and failing to disclose its potential for addiction.

That consent agreement required Purdue to correct its allegedly abusive and excessive marketing practices, maintain a program to identify prescribers who over-prescribe OxyContin and train sales representatives in the abuse and diversion detection program before they can promote the drug.

Since that time, Wilson said the company has continued to mislead doctors about the risks of addiction, by saying that patients who appeared addicted actually needed more opioids, and that opioid drugs could be taken in even higher doses without disclosing the greater risks to patients.

"We do not believe that a single lawsuit against a single company will magically fix the problem," Wilson said Tuesday. "But what I can do today as South Carolina's chief legal officer is to bring this lawsuit against Purdue for its deceit and misrepresentation."

Wilson said South Carolina had the ninth highest rate of opioid prescriptions in the nation last year. Since 2011, prosecutors said, more than 3,000 South Carolinians have died from prescription opioid overdoses.

"OxyContin accounts for less than 2% of the opioid analgesic prescription market nationally, but we are an industry leader in the development of abuse-deterrent technology, advocating for the use of prescription drug monitoring programs and supporting access to Naloxone - all important components for combating the opioid crisis," the Stamford, Conn.-based company said.

But the lawsuit accuses Purdue of falsely claiming that its newer, abuse-deterrent opioids are safer than other opioid drugs.

South Carolina has already won millions from another drug company over unfair trade practice allegations. In 2011, a Johnson & Johnson subsidiary was ordered to pay the state $327 million for downplaying to doctors the links between diabetes and Risperdal. The award represented a $300 penalty per sample box of the drug that was distributed, plus $4,000 for each letter the company wrote to doctors.

This latest lawsuit drew praise from state Rep. Eric Bedingfield, whose son Josh died last year of an overdose. He hopes state lawmakers also will keep working to combat addiction when they return to session in January, but says it will take more than lawsuits and legislation.

"Government can't fix this problem," Bedingfield said Tuesday, holding a large photograph of his son. "This is a people problem. ... These people have a disease, and they need to be treated with respect and dignity."

Explore further: Ohio sues five drugmakers over role in opioid crisis

Related Stories

Ohio sues five drugmakers over role in opioid crisis

May 31, 2017
The US state of Ohio on Wednesday sued five major producers of prescription opioid medications, accusing them of lying about the deadly risks the painkillers—at the center of a nationwide addiction crisis—posed to public ...

US city sues maker of painkiller OxyContin

January 20, 2017
A small US city on Thursday filed a lawsuit against Purdue Pharma, the maker of the pain reliever OxyContin, accusing the company of helping fuel an opioid crisis that has devastated the town.

FDA panel: Not enough data to OK "abuse-deterrent" opioid

July 26, 2017
A panel of Food and Drug Administration advisers voted against approving a new opioid painkiller with a unique feature for deterring abuse: It releases a deep-blue dye if someone tries to get high by crushing, chewing or ...

Opioid abuse down in younger americans, but up among older adults

July 26, 2017
(HealthDay)—While opioid abuse has fallen among younger Americans, the same cannot be said for older adults, a new government report shows.

Policy changes reduced use of certain prescription opioids: study

August 1, 2017
(HealthDay)—Tighter U.S. government restrictions on prescription painkillers containing hydrocodone led to reduced use of opioid medications such as Vicodin, a new study says.

Trump declares opioid crisis a 'national emergency'

August 11, 2017
US President Donald Trump said Thursday that the opioid crisis in the United States constitutes a "national emergency" and pledged to step up efforts to fight the epidemic.

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Aug 16, 2017
The cure for oxycodone addiction is trivial: 250mg of healthy adult male facial skin surface lipid p.o. 1 X. Avoid the airborne vapor from the skin surface lipid as it is highly aversive.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.